Skip to content
Blog News
About Us
Contact Us
Become One
Student
Individual
Fellow
Blog News
About Us
Contact Us
Become One
Student
Individual
Fellow
Login
Respiratory Syncytial Virus (RSV)
Respiratory Syncytial Virus (RSV)
Latest Posts
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody
May 10, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV studies identify risk factors in older adults, household transmission routes
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Study shows nirsevimab provides significant protection against RSV
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Reports describe good maternal RSV vaccine, drug uptake in their first season
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV vaccine prompts robust immune response in older recipients over 2 seasons
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
US flu activity climbs, with more deaths in kids
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
VA study shows COVID more severe than RSV, flu
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
US flu markers show more rises as COVID levels decline
April 4, 2025
Load More
Latest Posts
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody
May 10, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV studies identify risk factors in older adults, household transmission routes
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Study shows nirsevimab provides significant protection against RSV
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
Reports describe good maternal RSV vaccine, drug uptake in their first season
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
RSV vaccine prompts robust immune response in older recipients over 2 seasons
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
US flu activity climbs, with more deaths in kids
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
VA study shows COVID more severe than RSV, flu
April 4, 2025
Cidrap EDU
,
Respiratory Syncytial Virus (RSV)
,
RSS
US flu markers show more rises as COVID levels decline
April 4, 2025
Load More
Notifications
